Psychiatry and Clinical Neurosciences
April 18, 2023
Lucy Chester, Lucia Valmaggia, Matthew J. Kempton et al.
Evidence for case–control studies suggests that cannabis use is a risk factor for the development of psychosis. However, there have been limited prospective studies and the direction of this association remains controversial. The primary aim of the present study was to examine the association between cannabis use and the incidence of psychotic disorders in people at clinical high risk of...
2020
D. Oliver, Gemma Modinos, P. McGuire
Abstract Although clinical intervention at the clinical high risk stage has the potential to prevent the onset of psychosis, there are still no licensed pharmacological treatments for this purpose. The development of preventative treatments is informed by models of psychosis onset, especially those that reflect the time course and symptomatology of the disorder. This chapter describes four...
Clinical Psychological Science
June 20, 2017
Vaughan Bell, K. Mills, Gemma Modinos et al.
Poletti, Gebhardt, Krueger, and Raballo (2017) raise the important issue of a careful phenomenological approach in understanding the experience of psychosis in their helpful commentary on our recent article (Bell, Mills, Modinos, & Wilkinson, 2017). To summarize their main concern, they argue that the breadth of subjective and intersubjective experience in psychosis cannot be reduced to...
Clinical Psychological Science
February 10, 2017
Vaughan Bell, Kathryn L. Mills, Gemma Modinos et al.
47 citations
The positive symptoms of psychosis largely involve the experience of illusory social actors and yet our current measures of social cognition, at best, only weakly predict their presence. We review evidence to suggest that the range of current approaches in social cognition is not sufficient to explain the fundamentally social nature of these experiences. We argue that social agent...